[Translated Article] Disease-modifying treatments for patients with multiple sclerosis in Spain
CONCLUSIONS: We have described the disease-modifying treatment of patients with multiple sclerosis seen in Spanish pharmacy services and characterized concomitant treatments, the prevalence of polypharmacy, interactions, and their complexity.PMID:37394376 | DOI:10.1016/j.farma.2023.05.005
Source: Farmacia Hospitalaria - Category: Drugs & Pharmacology Authors: Alejandro Santiago P érez Santos Esteban Casado Miriam Álvarez Payero Ángel Escolano Pueyo Ángel Guillermo Arévalo Bernabé N úria Padullés Zamora Pilar Diaz Ruiz Ana Mar ía López González Source Type: research
More News: Cardiology | Cardiovascular | Copaxone | Disability | Drugs & Pharmacology | Heart | Multiple Sclerosis | Spain Health | Study | Tysabri